Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy

被引:0
|
作者
Cannie, D. [1 ,2 ]
Bakalakos, A. [1 ,2 ]
Protonotarios, A. [1 ,2 ]
Syrris, P. [1 ]
Lorenzini, M. [1 ,2 ]
Guttmann, O. [1 ,2 ]
O'mahony, C. [1 ,2 ]
Savvatis, K. [1 ,2 ]
Lopes, L. [1 ,2 ]
Sekhri, N. [2 ]
Mohiddin, S. [2 ]
Elliott, P. [1 ,2 ]
机构
[1] UCL, London, England
[2] Barts Heart Ctr, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Effect of pimobendan on end-stage heart failure in a mouse model of inherited dilated cardiomyopathy
    Nonaka, Miki
    Morimoto, Sachio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S76 - S76
  • [2] Therapeutic effect of pimobendan on end-stage heart failure in a mouse model of dilated cardiomyopathy
    Nonaka, Miki
    Morimoto, Sachio
    Li, Lei
    Kitamura, Yutaka
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 241P - 241P
  • [3] Restrictive mitral annuloplasty for end-stage heart failure due to idiopathic dilated cardiomyopathy
    Saito, Shunsuke
    Matsumiya, Goro
    Sakaguci, Taichi
    Fujita, Tomoyuki
    Takeda, Koji
    Taniguchi, Kazuhiro
    Masai, Takafumi
    Sakata, Yasushi
    Sawa, Yoshiki
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : S155 - S155
  • [4] TREATMENT OF END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    MOORE, CK
    WATERER, HC
    BRITISH HEART JOURNAL, 1994, 72 (06): : S52 - S56
  • [5] Challenges of Palliative Treatment for End-Stage Heart Failure "From a Report of Severe Heart Failure Due to Dilated Cardiomyopathy"
    Oishi, Shogo
    Toba, Takayoshi
    Miyoshi, Naoki
    Takaya, Tomofumi
    Tsukishiro, Yasue
    Yamada, Shinichiro
    Taniguchi, Yasuyo
    Hayashi, Takatoshi
    Yokoyama, Mitsuhiro
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S177 - S177
  • [6] Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy
    Zhu, Xiaoming
    Wang, Hongjiang
    Liu, Fan
    Chen, Li
    Luo, Weijia
    Su, Pixiong
    Li, Weiming
    Yu, Liping
    Yang, Xinchun
    Cai, Jun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (09) : 1173 - 1187
  • [7] THE ROLE OF MYOCARDITIS IN END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    TEXAS HEART INSTITUTE JOURNAL, 1987, 14 (03) : 268 - 275
  • [8] Familial Dilated Cardiomyopathy (FDCM) Prevalence in End-Stage Non-Ischemic Heart Failure (ESHF)
    Jacoby, D. L.
    DePasquale, E. C.
    Lour, O.
    Pomianowski, P.
    McKenna, W. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S52 - S52
  • [9] Reverse left ventricular remodeling by dobutamine and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy
    Maroulidis, G
    Alexopoulos, G
    Ntalianis, A
    Drakos, S
    Venetsanakos, J
    Christodoulou, K
    Kopelia, M
    Sarafoglou, S
    Savvari, V
    Anastasiou-Nana, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S158 - S158
  • [10] Frequency of viral persistence in end-stage dilated cardiomyopathy
    Mahon, NG
    Risley, P
    Zal, B
    Baboonian, C
    Davies, MJ
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 166A - 166A